News & Resources

The law firm of Alley, Clark & Greiwe represents a large number of clients who have been injured by defective metal-on-metal hip replacement devices sold by various manufacturers. A new Stryker Settlement Agreement was announced last week to compensate eligible U.S. patients who were forced to undergo revision surgery before November 3, 2014 to replace their recalled Stryker Rejuvenate Hip System. Patients eligible for compensation under the Settlement Program should speak with an attorney as soon as possible regarding eligibility since the deadline to register for the settlement expires on December 14, 2014.

Under the terms of the settlement program, Stryker will provide a base payment of $300,000 to patients that received the Rejuvenate or ABG II hip systems and underwent revision surgery before November 3, 2014, due to a failure of the recalled hip device. The base award is subject to certain deductions based upon a claimant's age at the time of the initial surgery as well as other factors. Claimants may also be awarded additional compensation separately from the base payment if they suffered from specific complications during or after revision surgery.

Background on Stryker Recall

Stryker Orthopaedics voluntarily recalled its Rejuvenate and ABG II modular neck hip implant stems on July 4, 2012. This voluntary recall was initiated due to widespread problems including pain, swelling, and tissue damage associated in patients with these metal-on-metal modular neck stems. According to Stryker, the risks include the potential for "fretting" and/or corrosion around the modular-neck junction which may result in adverse local tissue reactions.

Please contact Alley, Clark & Greiwe if you would like more information about the Stryker recall or the metal-on-metal hip litigation.

Please click here to read more about the Stryker hip settlement.

Please click here to read more about the Stryker hip recall.